Kennedy Legel, DPM
Foot & Ankle Surgery · Dallas, TXNPI 1558500801
Payments from drug & device makers
Across 338 payments — averaging $31.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Stryker$1K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$944
- Kerecis Limited$685
- Convatec Inc.$476
- International Life Sciences$407
- plus $5K from 50 others
What the payments were for
- Travel & lodging$4124%
- Food & beverage$10,21696%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$818
- CYTAL$517
- Kerecis Omega3 GraftGuide$387
- FLEXBAND$324
- InnovaMatrix AC$282
- Kerecis Omega3 Marigen$216
- Kerecis Omega3 Wound$171
- Kerecis Omega3 Surgibind$171
- Foot/ankle products$159
- EVOS$159
- Viaflow$155
- PROSTEP MICA$155
- RINGFIX$150
- CERAMENTBONE VOID FILLER$150
- CERAMENT G$150
- Product Portfolio$145
- GRAFIX PL$141
- Qutenza$140
- Bone Anchors with Arthroscopic Delivery System$139
- Omnia$138
How this compares
$10,647 in reported general payments places this provider in the 70th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tavaborole | 28 | $7,779 |
| Cephalexin | 18 | $386 |
| Terbinafine Hcl | 12 | $157 |
| Gabapentin | 13 | $148 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $84 |
| Methylprednisolone | 14 | $67 |
| Meloxicam | 16 | $48 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Dallas
- Eugene CurryDallas$3.1M
- Paul KimDallas$972K
- John EarlyDallas$572K
- John NoackDallas$389K
- Dane WukichDallas$273K
- Charles CookDallas$192K
- George LiuDallas$130K
- Trapper LalliDallas$92K
- Veerabhadra ReddyDallas$59K
- Richard PollakSan Antonio$6.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.